Difficult choice between various antipsychotic agents--should we broaden our view?
Lehtonen, J.; Tacke, U.
Duodecim; Laaketieteellinen Aikakauskirja 119(12): 1159-1162
2003
ISSN/ISBN: 0012-7183 PMID: 12868363 Document Number: 562418
Document emailed within 1 workday
Related Documents
Rimón, R.; Leinonen, E. 2002: Should the second generation antipsychotic agents be used as drugs of choice? Duodecim; Laaketieteellinen Aikakauskirja 118(6): 585-590Diurni, M.; Baranzini, F.; Costantini, C.; Poloni, N.; Vender, S.; Callegari, C. 2009: Metabolic side effects of second generation antipsychotic agents in antipsychotic-naïve patients: preliminary study Recenti Progressi in Medicina 100(2): 103
Nightengale, B.S.; Crumly, J.M.; Liao, J.; Lawrence, B.J.; Jacobs, E.W. 1998: Economic outcomes of antipsychotic agents in a Medicaid population: traditional agents vs. risperidone Psychopharmacology Bulletin 34(3): 373-382
Gosselin, O.; Di Scala, G.; Ribeyre, J.M.; Kahn, J.P. 1996: New antipsychotic agents: new paths of research on the notion of atypical agents L'Encephale 22(Special Issue 6): 3-6
2003: Choice of an antipsychotic Medical Letter on Drugs and Therapeutics 45(1172): 102-104
Dresse, A. 1996: Neuroleptics or antipsychotic agents Revue Medicale de Liege 51(1): 65-69
Casey, D.E. 1996: Side effect profiles of new antipsychotic agents Journal of Clinical Psychiatry 57(Suppl): 40-45; Discussion 46-52
Omori, T. 2001: Efficacy of atypical antipsychotic agents for maintenance therapy of schizophrenia Seishin Shinkeigaku Zasshi 103(6): 470-475
Lance, P. 1974: Cast or screws? a difficult and always controversial choice La Revue du Praticien 24(41): 3593-3594 Passim
Gram, L.F. 2000: Malignant neuroleptic syndrome in treatment with the new, atypical antipsychotic agents, risperidone and olanzapine Ugeskrift for Laeger 162(13): 1914-1915
Roth, B.L.; Ciaranello, R.D.; Meltzer, H.Y. 1992: Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors Journal of Pharmacology and Experimental Therapeutics 260(3): 1361-1365
Glaser, B.A.; Morreau, L.E. 1986: Effects of interdisciplinary team review on the use of antipsychotic agents with severely and profoundly mentally retarded persons American Journal of Mental Deficiency 90(4): 371-379
Sedvall, G.; Nybäck, H. 1973: Effect of clozapine and some other antipsychotic agents on synthesis and turnover of dopamine formed from 14C-tyrosine in mouse brain Israel Journal of Medical Sciences 9 Suppl: 24-30
Keen, E.N.; Fredman, M. 1982: Multiple-choice examinations--an objective view South African Medical Journal 62(13): 425
Eberle, P. 1970: Chromosomal points of view in the choice of experimental objects Medizinische Monatsschrift 24(10): 448-453
Roth, B.L.; Craigo, S.C.; Choudhary, M.S.; Uluer, A.; Monsma, F.J.; Shen, Y.; Meltzer, H.Y.; Sibley, D.R. 1994: Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors Journal of Pharmacology and Experimental Therapeutics 268(3): 1403-1410
Pollini, J.; Teissier, M. 1990: A difficult dilemma to resolve: aged patients refused for treatment by iterative hemodialysis. Ethical problem or medical choice? Reflections apropos of a questionnaire-inquiry Nephrologie 11(5): 341-347
Viukari, M. 1980: Problems in the choice of tranquilizing agents Duodecim; Laaketieteellinen Aikakauskirja 96(9): 679-687
Wunderlich, H.F.; Raff, M.J.; Melo, J.C. 1979: A clinical approach to the choice of antimicrobial agents Journal of the Kentucky Medical Association 77(1): 11-12
Parekh, M.C.; Murphy, Y.S.; Arronet, G.H.; Latour, R. 1971: Estro-progestational agents; their choice and utilization in family planning. 2 L'Union Medicale du Canada 100(9): 1818-1820